Stockreport

ImmunityBio (IBRX) Climbs 7.76% on Europe Expansion [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF ImmunityBio jumped by 7.76 percent on Friday to close at $2.36 apiece after securing the green light of the European Medicines Agency (EMA) to sell its bladder cancer t [Read more]